- Home
- ABCL vs CSTL Comparison
ABCL vs CSTL Comparison
Compare ABCL & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABCL
- CSTL
- Stock Information
- Founded
- ABCL 2012
- CSTL 2007
- Country
- ABCL Canada
- CSTL United States
- Employees
- ABCL N/A
- CSTL N/A
- Industry
- ABCL Biotechnology: Pharmaceutical Preparations
- CSTL Medical Specialities
- Sector
- ABCL Health Care
- CSTL Health Care
- Exchange
- ABCL Nasdaq
- CSTL Nasdaq
- Market Cap
- ABCL 818.2M
- CSTL 848.1M
- IPO Year
- ABCL 2020
- CSTL 2019
- Fundamental
- Price
- ABCL $2.97
- CSTL $24.94
- Analyst Decision
- ABCL Buy
- CSTL Strong Buy
- Analyst Count
- ABCL 3
- CSTL 6
- Target Price
- ABCL $8.00
- CSTL $40.33
- AVG Volume (30 Days)
- ABCL 3.2M
- CSTL 434.0K
- Earning Date
- ABCL 02-18-2025
- CSTL 02-26-2025
- Dividend Yield
- ABCL N/A
- CSTL N/A
- EPS Growth
- ABCL N/A
- CSTL N/A
- EPS
- ABCL N/A
- CSTL 0.21
- Revenue
- ABCL $32,962,000.00
- CSTL $311,878,000.00
- Revenue This Year
- ABCL N/A
- CSTL $51.29
- Revenue Next Year
- ABCL $36.56
- CSTL N/A
- P/E Ratio
- ABCL N/A
- CSTL $118.55
- Revenue Growth
- ABCL N/A
- CSTL 62.43
- 52 Week Low
- ABCL $2.34
- CSTL $16.97
- 52 Week High
- ABCL $5.62
- CSTL $35.84
- Technical
- Relative Strength Index (RSI)
- ABCL 50.75
- CSTL 36.58
- Support Level
- ABCL $2.81
- CSTL $23.95
- Resistance Level
- ABCL $3.09
- CSTL $26.52
- Average True Range (ATR)
- ABCL 0.20
- CSTL 2.08
- MACD
- ABCL -0.02
- CSTL -0.36
- Stochastic Oscillator
- ABCL 30.28
- CSTL 11.26
About ABCL AbCellera Biologics Inc.
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company have extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.
About CSTL Castle Biosciences Inc.
Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others.